Code | Description |
---|---|
J3489 | Injection, zoledronic acid, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Osteoporosis | D010024 | HP_0000939 | M81.0 | 1 | 12 | 26 | 20 | 18 | 76 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 7 | 20 | 30 | 9 | 10 | 71 |
Prostatic neoplasms | D011471 | — | C61 | 4 | 12 | 14 | 13 | 5 | 46 |
Multiple myeloma | D009101 | — | C90.0 | 1 | 9 | 6 | 7 | 3 | 26 |
Neoplasms | D009369 | — | C80 | 3 | 6 | 9 | 1 | 5 | 22 |
Postmenopausal osteoporosis | D015663 | EFO_0003854 | — | — | 1 | 2 | 12 | 5 | 20 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | 3 | 3 | 7 | 1 | 15 |
Pain | D010146 | EFO_0003843 | R52 | 2 | 2 | 7 | 1 | 3 | 13 |
Non-small-cell lung carcinoma | D002289 | — | — | — | 5 | 2 | 4 | 1 | 12 |
Metabolic bone diseases | D001851 | HP_0000938 | — | — | 3 | 4 | 1 | 2 | 10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 1 | 2 | 3 | — | 1 | 7 |
Hypercalcemia | D006934 | HP_0003072 | E83.52 | 1 | 1 | 3 | — | 2 | 6 |
Plasma cell neoplasms | D054219 | — | — | 2 | 1 | 2 | — | 1 | 5 |
Giant cell tumor of bone | D018212 | — | — | 1 | 3 | 1 | — | — | 4 |
Osteosarcoma | D012516 | — | — | 2 | 1 | 1 | — | — | 3 |
Sarcoma | D012509 | — | — | 1 | — | 1 | — | — | 2 |
Beta-thalassemia | D017086 | Orphanet_848 | D56.1 | — | 1 | 2 | — | — | 2 |
Lymphoma | D008223 | — | C85.9 | — | 1 | 1 | — | — | 2 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | — | 1 | — | — | 2 |
Ewing sarcoma | D012512 | EFO_0000173 | — | 1 | — | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Osteonecrosis | D010020 | EFO_0004259 | M87 | — | 3 | — | — | 2 | 5 |
Progeria | D011371 | EFO_0000671 | E34.8 | — | 3 | — | — | — | 3 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | 1 | 3 | — | — | — | 3 |
Drug therapy | D004358 | — | — | — | 1 | — | — | 1 | 2 |
Myelodysplastic syndromes | D009190 | — | D46 | 1 | 1 | — | — | — | 2 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 2 | — | — | — | 2 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 1 | 1 | — | — | — | 2 |
Uterine cervical neoplasms | D002583 | HP_0030159 | — | 1 | 1 | — | — | — | 2 |
Macular degeneration | D008268 | EFO_0001365 | H35.30 | — | 1 | — | — | — | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neuroblastoma | D009447 | EFO_0000621 | — | 5 | — | — | — | — | 5 |
Adenocarcinoma | D000230 | — | — | 2 | — | — | — | — | 2 |
Hematopoietic stem cell transplantation | D018380 | — | — | 1 | — | — | — | 1 | 2 |
Secondary hyperparathyroidism | D006962 | EFO_1001173 | — | 1 | — | — | — | — | 1 |
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | — | — | — | — | 1 |
Hodgkin disease | D006689 | — | C81 | 1 | — | — | — | — | 1 |
Rhabdomyosarcoma | D012208 | — | — | 1 | — | — | — | — | 1 |
Primitive neuroectodermal tumors | D018242 | — | — | 1 | — | — | — | — | 1 |
Chondrosarcoma | D002813 | — | — | 1 | — | — | — | — | 1 |
Precancerous conditions | D011230 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bisphosphonate-associated osteonecrosis of the jaw | D059266 | — | — | — | — | — | — | 2 | 2 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | — | 2 | 2 |
Musculoskeletal pain | D059352 | — | — | — | — | — | — | 2 | 2 |
Infections | D007239 | EFO_0000544 | — | — | — | — | — | 1 | 1 |
Femoral fractures | D005264 | — | S72 | — | — | — | — | 1 | 1 |
Healthy volunteers/patients | — | — | — | — | — | — | — | 1 | 1 |
Renal insufficiency | D051437 | HP_0000083 | N19 | — | — | — | — | 1 | 1 |
Ductal carcinoma breast | D018270 | — | — | — | — | — | — | 1 | 1 |
Mortality | D009026 | EFO_0004352 | — | — | — | — | — | 1 | 1 |
Drug common name | Zoledronic acid |
INN | zoledronic acid |
Description | Zoledronic acid is an imidazole compound having a 2,2-bis(phosphono)-2-hydroxyethane-1-yl substituent at the 1-position. It has a role as a bone density conservation agent. It is a member of imidazoles and a 1,1-bis(phosphonic acid). |
Classification | Small molecule |
Drug class | calcium metabolism regulators |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O |
PDB | — |
CAS-ID | 118072-93-8 |
RxCUI | 1546014 |
ChEMBL ID | CHEMBL924 |
ChEBI ID | 46557 |
PubChem CID | 68740 |
DrugBank | DB00399 |
UNII ID | 70HZ18PH24 (ChemIDplus, GSRS) |